Dermavant

Dermavant CEO draws Botox comparison to instill Vtama confidence

Dermavant CEO Todd Zavodnick isn’t worried about the disappointing uptake of Vtama, saying it will flourish when it is approved for atopic dermatitis.

Kevin Dunleavy Nov 28, 2023 4:10pm

With Dermavant's Vtama struggling, Leerink slashes projections

Nov 14, 2023 11:13am

Dermavant strengthens approval bid for Vtama in eczema

Oct 12, 2023 8:50am

Incyte's Opzelura hits goal in eczema trial in young kids

Jul 12, 2023 10:30am

Dermavant bolsters Vtama's case for approval in eczema

May 16, 2023 8:25am

Dermavant's Vtama cream hits goal in first eczema phase 3 study

Mar 15, 2023 11:42am